MNPR: Monopar Therapeutics Inc. Stock

by  •  • Comments Off on MNPR: Monopar Therapeutics Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 10.96
Enterprise Value ($M) 3.70
Book Value ($M) 5.59
Book Value / Share 0.32
Price / Book 1.96
NCAV ($M) 5.58
NCAV / Share 0.32
Price / NCAV 1.97

Profitability (mra)
Return on Invested Capital (ROIC) -1.50
Return on Assets (ROA) -0.71
Return on Equity (ROE) -0.94

Liquidity (mrq)
Quick Ratio 4.17
Current Ratio 4.17

Balance Sheet (mrq) ($M)
Current Assets 7.33
Assets 7.35
Liabilities 1.76
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -8.83
Net Income -8.40
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -7.86
Cash from Investing 4.93
Cash from Financing 2.03

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
06-02 13G Klunzinger Jeffrey R. 5.24

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-28 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-05-11 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-26 6,015 9,067 66.34
2024-04-25 11,433 14,256 80.20
2024-04-24 13,571 4,386 309.42
2024-04-23 23,521 4,323 544.09

(click for more detail)

Similar Companies
MEIP – MEI Pharma, Inc. MIRA – MIRA Pharmaceuticals, Inc.
MLTX – MoonLake Immunotherapeutics MRKR – Marker Therapeutics, Inc.
MTEM – Molecular Templates, Inc.


Financial data and stock pages provided by
Fintel.io